Brief: Yichang Hec Changjiang Pharma Says ot Approval To Launch Escitalopram Oxalate Tablets
19/04/2021 12:32
April 19 (Reuters) - YiChang HEC ChangJiang Pharmaceutical
Co Ltd 1558.HK :
* ESCITALOPRAM OXALATE TABLETS (5MG, 10MG, 15MG AND 20MG)
GOT NOD
FOR LAUNCH FROM CHINA NMPA
Source text for Eikon: ID:nHKS5xc25p
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million